Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Sales | 5,414 | 1,404 |
| Cost of Goods | 527 | 453 |
| Gross Profit | 4,887 | 951 |
| Operating Expenses | 7,048 | 2,760 |
| Operating Income | -1,634 | -1,356 |
| Other Income | -9,844 | -1,075 |
| Pre-tax Income | -11,478 | -2,431 |
| Income Tax | 6 | N/A |
| Net Income Continuous | -11,484 | -2,431 |
| Net Income | $-11,484 | $-2,431 |
| EPS Basic Total Ops | -0.79 | -0.22 |
| EPS Basic Continuous Ops | -0.79 | -0.22 |
| EPS Diluted Total Ops | -0.79 | -0.22 |
| EPS Diluted Continuous Ops | -0.79 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.79 | -0.22 |
| EBITDA(a) | $-1,601 | $-1,317 |